Latest filing published 29 Aug 2016 for Humanigen, INC, €5.3M.
Insider track record
Closed purchases
Based on 40 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +101.6%Entry US$11.00 · Close at T+365 US$22.18
- +105.8%Entry US$10.60 · Close at T+365 US$21.81
- +135.5%Entry US$10.66 · Close at T+365 US$25.10
- +141.7%Entry US$11.82 · Close at T+365 US$28.57
- +15.6%Entry US$20.37 · Close at T+365 US$23.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin Shkreli: trading record in brief
Martin Shkreli is a declared insider at 2 companies; the most frequent names are Travere Therapeutics, Inc. and Humanigen, Inc. The record holds 63 filings, for trades running from 12 December 2012 to 26 August 2016.
Market trades split into 48 purchases (€6.7M) and 10 sales (€17.6M). The net balance comes to €10.9M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2016 alone, the filings show no purchases and 2 sales.
The median purchase comes to €48k. Looking at 40 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +7.4%. Past outcomes like these are no guarantee of what comes next.
On 29 August 2016 came the latest disclosure, an open-market sale for €5.3M in Humanigen, Inc. The last insider purchase was made public on 24 November 2015, 4,002 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Shkreli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,913,206 shares@ US$3.1086.1% of flowCommon StockSEC:0001104659-16-141736:0
- 309,723 shares@ US$3.1013.9% of flowCommon StockSEC:0001104659-16-141736:1
- 5,000 shares@ US$38.15Common StockSEC:0001144204-15-067701:0Canonical exit: 22 Feb 2016 (T+90)
- 5,000 shares@ US$18.88Common StockSEC:0001144204-15-067473:0Canonical exit: 18 Feb 2016 (T+90)
- 440,000 shares@ US$2.02Common StockSEC:0001144204-15-066900:0Canonical exit: 16 Feb 2016 (T+90)
- 500,169 shares@ US$0.61Common StockSEC:0001144204-15-066696:0Canonical exit: 14 Feb 2016 (T+90)
- 97,269 shares@ US$1.43Common StockSEC:0001144204-15-066696:1Canonical exit: 14 Feb 2016 (T+90)
- 606,677 shares@ US$1.93Common StockSEC:0001144204-15-066696:2Canonical exit: 15 Feb 2016 (T+90)
- 7,000 shares@ US$2.43Common StockSEC:0001144204-15-066696:3Canonical exit: 15 Feb 2016 (T+90)
- 100,000 shares@ US$9.41Common StockSEC:0001213900-14-008549:1
- 254,975 shares@ US$9.19Common StockSEC:0001213900-14-008549:2
- 329,824 shares@ US$8.54Common StockSEC:0001213900-14-008549:3
- 134,354 shares@ US$8.23Common StockSEC:0001213900-14-008549:4
- 252,847 shares@ US$8.41Common StockSEC:0001213900-14-008549:5
- 100,000 shares@ US$10.23Common StockSEC:0001213900-14-008549:0
- 25,000 shares@ US$8.1066Common StockSEC:0001193805-14-001950:0Canonical exit: 30 Dec 2014 (T+90)
- 300,000 shares@ US$0.01Common StockSEC:0001193805-14-001950:1
- 332,980 sharesCommon StockSEC:0001193805-14-001950:2
- 4,000 shares@ US$9.42Common StockSEC:0001193805-14-001927:0Canonical exit: 29 Dec 2014 (T+90)
- 18,000 shares@ US$11.78Common StockSEC:0001193805-14-001860:0Canonical exit: 18 Dec 2014 (T+90)
- 35,000 shares@ US$10.82Common StockSEC:0001193805-14-001860:1Canonical exit: 21 Dec 2014 (T+90)
- 6,000 shares@ US$11.46Common StockSEC:0001193805-14-001834:0Canonical exit: 16 Dec 2014 (T+90)
- 7,500 shares@ US$10.69Common StockSEC:0001193805-14-001829:0Canonical exit: 15 Dec 2014 (T+90)
- 50,000 shares@ US$14.62Common StockSEC:0001193805-14-001168:0
- 126,388 shares@ US$14.62Common StockSEC:0001193805-14-001168:1
25 of 63 declarations
